Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
25
27
28
29
1
3
5
6
7
8
11
13
15
17
18
19
20
21
22
24
25
27
28
29
31
1
2
3
4
5
3rd International conference on  Diabetes, Hypertension and Metabolic Syndrome
2020-02-24 - 2020-02-25    
All Day
About Diabetes Meet 2020 Conference Series takes the immense Pleasure to invite participants from all over the world to attend the 3rdInternational conference on Diabetes, Hypertension and [...]
3rd International Conference on Cardiology and Heart Diseases
2020-02-24 - 2020-02-25    
All Day
ABOUT 3RD INTERNATIONAL CONFERENCE ON CARDIOLOGY AND HEART DISEASES The standard goal of Cardiology 2020 is to move the cardiology results and improvements and to [...]
Medical Device Development Expo OSAKA
2020-02-26 - 2020-02-28    
All Day
ABOUT MEDICAL DEVICE DEVELOPMENT EXPO OSAKA What is Medical Device Development Expo OSAKA (MEDIX OSAKA)? Gathers All Kinds of Technologies for Medical Device Development! This [...]
Beauty Care Asia Pacific Summit 2020 (BCAP)
2020-03-02 - 2020-03-04    
All Day
Groundbreaking Event to Address Asia-Pacific’s Growing Beauty Sector—Your Window to the World’s Fastest Growing Beauty Market The international cosmetics industry has experienced a rapid rise [...]
IASTEM - 789th International Conference On Medical, Biological And Pharmaceutical Sciences ICMBPS
2020-03-04 - 2020-03-05    
All Day
IASTEM - 789th International Conference on Medical, Biological and Pharmaceutical Sciences ICMBPS will be held on 4th - 5th March, 2020 at Hamburg, Germany . [...]
Global Drug Delivery And Formulation Summit 2020
2020-03-09 - 2020-03-11    
All Day
Innovative solutions to the greatest challenges in pharmaceutical development. Price: Full price delegate ticket: GBP 1495.0. Time: 9:00 am to 6:00 pm About Conference KC [...]
Inborn Errors Of Metabolism Drug Development Summit 2020
2020-03-10 - 2020-03-12    
All Day
Confidently Translate, Develop and Commercialize Gene, mRNA, Replacement Therapies, Small Molecule and Substrate Reduction Therapies to More Efficaciously Treat Inherited Metabolic Diseases. Time: 8:00 am [...]
Texting And E-Mail With Patients: Patient Requests And Complying With HIPAA
2020-03-12    
All Day
Overview:  This session will focus on the rights of individuals to communicate in the manner they desire, and how a medical office can decide what [...]
14 Mar
2020-03-14 - 2020-03-21    
All Day
Topics in Family Medicine, Hematology, and Oncology CME Cruise. Prices: USD 495.0 to USD 895.0. Speakers: David Parrish, MS, MD, FAAFP, Alexander E. Denes, MD, [...]
International Conference On Healthcare And Clinical Gerontology ICHCG
2020-03-14 - 2020-03-15    
All Day
An elegant and rich premier global platform for the International Conference on Healthcare and Clinical Gerontology ICHCG that uniquely describes the Academic research and development [...]
World Congress And Expo On Cell And Stem Cell Research
2020-03-16 - 2020-03-17    
All Day
"The world best platform for all the researchers to showcase their research work through OralPoster presentations in front of the international audience, provided with additional [...]
25th International Conference on  Diabetes, Endocrinology and Healthcare
2020-03-23 - 2020-03-24    
All Day
About Conference: Conference Series LLC Ltd is overwhelmed to announce the commencement of “25th International Conference on Diabetes, Endocrinology and Healthcare” to be held during [...]
ISN World Congress of Nephrology 2020
2020-03-26 - 2020-03-29    
All Day
ABOUT ISN WORLD CONGRESS OF NEPHROLOGY 2020 ISN World Congress of Nephrology (WCN) takes place annually to enable this premier educational event more available to [...]
30 Mar
2020-03-30 - 2020-03-31    
All Day
This Cardio Diabetes 2020 includes Speaker talks, Keynote & Poster presentations, Exhibition, Symposia, and Workshops. This International Conference will help in interacting and meeting with diabetes and [...]
Trending Topics In Internal Medicine 2020
2020-04-02 - 2020-04-04    
All Day
Trending Topics in Internal Medicine is a CME course that will tackle the latest information trending in healthcare today.   This course will help you discuss options [...]
2020 Summit On National & Global Cancer Health Disparities
2020-04-03 - 2020-04-04    
All Day
The 2020 Summit on National & Global Cancer Health Disparities is planned with the goal of creating a momentum to minimize the disparities in cancer [...]
Events on 2020-02-26
Events on 2020-03-02
Events on 2020-03-09
Events on 2020-03-10
Events on 2020-03-16
Events on 2020-03-26
Events on 2020-03-30
Events on 2020-04-02
Events on 2020-04-03
Articles

Do EHR Vendors Influence User’s Health Information Exchange?

Are EHR vendors to blame for lacking health data interoperability and health information exchange?

ehr-vendor-hie-interoperability

Recent research published in Health Affairs suggests they may be.

According to researchers Jordan Everson and Julia Adler-Milstein, hospitals in more competitive regional EHR markets engage in less health information exchange (HIE) than those in markets where there is one dominant EHR vendor.

According to the researchers, hospitals using the dominant EHR vendor in typical market landscapes engage in 45 percent more HIE than other hospitals. Those results changed when the EHR vendor markets changed.

When an EHR vendor had 20 percent market dominance, its users engaged in 59 percent more HIE than other hospitals. When the vendor controlled 80 percent of the market, its users engaged in only 25 percent more HIE than other hospitals.

This suggests that when an EHR vendor has less market dominance, its users can typically only exchange data with each other. When there is less competition, users are able to exchange data with other EHR users.

These results point to an issue with EHR vendors and the way they control EHR interoperability. When they are in a more competitive market landscape, vendors may potentially limit the amount of HIE hospitals can engage in with users of other vendors.

According to the researchers, this especially an issue with EHR vendor behemoth Epic Systems. Epic was the most dominant EHR included in the study, accounting for nearly a quarter of all beds in the study and used in 16.6 percent of the investigated hospitals.

When Everson and Adler-Milstein looked at markets in which Epic was the most dominant, they saw that users could almost exclusively exchange data with other Epic users.

The fact that when Epic was the dominant vendor we saw a different pattern—in which increasing dominance was not associated with greater HIE among hospitals that did not use Epic—may reflect the fact that Epic clients can readily exchange data with other Epic clients, and as a result, doing so with providers that are not Epic clients may appear prohibitively costly and complex.

This was a significant revelation considering the industry rumblings about Epic’s lack of inter-EHR HIE.

For their part, Epic has made moves to improve on its interoperability efforts. At the HIMSS 2016 conference, the vendor signed onto the Department of Health and Human Services (HHS)interoperability pledge.

Epic Systems CEO Judy Faulkner, has also defended the vendor’s interoperability efforts.

“We do about 26 million patient interoperability exchanges – that’s not the same thing as queries – every month,” Faulkner said in an interview with HealthITInteroperability.com.

“If it’s Epic-to-Epic, we’ve connected everyone,” she continued.  “If it’s Epic-to-non-Epic, we do it any time they have a C-CDA available, because technically speaking, it’s the same thing.  It doesn’t matter if it’s Allscripts or athenahealth or anyone.  We can do that just about as easily as we can do it with our own software.”

Regardless of those efforts, Everson and Adler-Milstein’s results still confirm what has recently been hypothesized throughout the healthcare industry: EHR vendors may influence HIE between different vendor users.

“If the dynamics we postulate are real, policy makers should consider pursuing targeted efforts to combat information-blocking practices and may be well served by creating stronger incentives for providers and vendors to pursue cross-vendor HIE, which has been successful in other nations,” Everson and Adler-Milstein wrote.

Going forward, researchers should continue to investigate these patterns, the researchers suggested. Those efforts could help confirm these initial findings.

If further research can confirm that EHR vendors influence HIE depending on market competition, Everson and Adler-Milstein suggest policymakers continue their efforts to monitor and enforce intentional data-blocking. By continuing those efforts, policymakers may help bring the industry closer to its goal of nationwide interoperability.

Source